Literature DB >> 32488203

Author Correction: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.

Miriam Merad1,2,3,4, Jerome C Martin5,6.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID: 32488203      PMCID: PMC7265161          DOI: 10.1038/s41577-020-0353-y

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


Nature Reviews Immunology (2020) 10.1038/s41577-020-0331-4 Published online 06 May 2020 In the originally published article, the imprecise wording of a sentence implied that IL-6 blockade had been approved by the FDA for treatment of COVID-19. This has now been corrected in the HTML and PDF versions of the article to clarify that the FDA had, at the time of writing, only approved trials of IL-6 blockade in patients with COVID-19.
  31 in total

Review 1.  COVID-19 in Africa: an ovarian victory?

Authors:  Osman A Dufailu; Afrakoma Afriyie-Asante; Bernard Gyan; David Adu Kwabena; Helena Yeboah; Frank Ntiakoh; Meshach Asare-Werehene
Journal:  J Ovarian Res       Date:  2021-05-21       Impact factor: 4.234

2.  Integration and Reanalysis of Four RNA-Seq Datasets Including BALF, Nasopharyngeal Swabs, Lung Biopsy, and Mouse Models Reveals Common Immune Features of COVID-19.

Authors:  Rudi Alberts; Sze Chun Chan; Qian-Fang Meng; Shan He; Lang Rao; Xindong Liu; Yongliang Zhang
Journal:  Immune Netw       Date:  2022-05-19       Impact factor: 5.851

3.  Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable.

Authors:  Yang Li; Peifa Yu; Amy L Kessler; Jingyi Shu; Xiaoyan Liu; Zhaochao Liang; Jiaye Liu; Yunlong Li; Pengfei Li; Ling Wang; Yining Wang; Zhongren Ma; Aixia Liu; Ling Wang; Marco J Bruno; Robert A de Man; Maikel P Peppelenbosch; Sonja I Buschow; Lin Wang; Yijin Wang; Qiuwei Pan
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

Review 4.  The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.

Authors:  Nohora Cristina Ayola-Serrano; Namrata Roy; Zareena Fathah; Mohammed Moustapha Anwar; Bivek Singh; Nour Ammar; Ranjit Sah; Areej Elba; Rawan Sobhi Utt; Samuel Pecho-Silva; Alfonso J Rodriguez-Morales; Kuldeep Dhama; Sadeq Quraishi
Journal:  Inflamm Res       Date:  2021-06-04       Impact factor: 6.986

Review 5.  The effect of estrogen in coronavirus disease 2019.

Authors:  Qing Ma; Zhuo-Wen Hao; Yan-Feng Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-05       Impact factor: 5.464

Review 6.  Intestinal viral infections of nSARS-CoV2 in the Indian community: Risk of virus spread in India.

Authors:  Harjeet S Maan; Deepti Chaurasia; Garima Kapoor; Lokendra Dave; Arshi Siddiqui; Savita Pal; Hari O Singh; Debasis Biswas; Rashmi Chowdhary
Journal:  J Med Virol       Date:  2021-12-03       Impact factor: 20.693

Review 7.  Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.

Authors:  Aikaterini Kountouri; Emmanouil Korakas; Ignatios Ikonomidis; Athanasios Raptis; Nikolaos Tentolouris; George Dimitriadis; Vaia Lambadiari
Journal:  Antioxidants (Basel)       Date:  2021-05-09

Review 8.  Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Authors:  Danielle Brain; Alex Plant-Hately; Bethany Heaton; Usman Arshad; Christopher David; Christian Hedrich; Andrew Owen; Neill J Liptrott
Journal:  Adv Drug Deliv Rev       Date:  2021-06-25       Impact factor: 17.873

Review 9.  Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2.

Authors:  Diego Fernández-Lázaro; Cesar I Fernandez-Lazaro; Juan Mielgo-Ayuso; David P Adams; Juan Luis García Hernández; Jerónimo González-Bernal; Marcela González-Gross
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

10.  HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.

Authors:  Christophe Desterke; Ali G Turhan; Annelise Bennaceur-Griscelli; Frank Griscelli
Journal:  J Transl Med       Date:  2021-07-05       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.